A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)
Stopped This study was terminated for administrative reasons. There were no safety concerns.
Conditions
Interventions
- DRUG: Dornase alfa
- DRUG: placebo
Sponsor
Genentech, Inc.